Study on Suprachoroidal Administration for Patients with Eye Metastasis from Breast or Lung Cancer
Sponsor: Aura Biosciences
ClinicalTrials ID:NCT06643884
This clinical trial is testing a new treatment called bel-sar to see if it is safe and well-tolerated in patients with eye metastasis originating from breast or lung cancer.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The main goal of this study is to evaluate the safety and tolerability of a treatment called bel-sar in patients who have eye metastasis from breast or lung cancer. The study will involve different doses and treatment cycles to find the best approach.
Description
This study is open-label, meaning both the researchers and participants know what treatment is being given. It is designed to test the safety and tolerability of bel-sar at four different dose levels. Participants will receive one or two cycles of treatment to see how well they tolerate it. The focus is on patients who have eye metastasis from breast or lung cancer, specifically in one eye only.
Eligibility Criteria
Inclusion Criteria
- Have been diagnosed with eye metastasis from a confirmed breast or lung cancer.
- Have a single eye metastasis in one eye only, with no metastasis in the other eye.
Exclusion Criteria
- Have an active eye infection or disease.
- Must not have a primary tumor or brain metastasis that requires radiation treatment, as determined by the primary oncologist.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| Byers Eye Institute at Stanford University | 94303 | Palo Alto | California |
| Bascom Palmer Eye Institute | 33136 | Miami | Florida |
| Massachusetts Eye and Ear | 02114 | Boston | Massachusetts |
| Kellogg Eye Center | 48105 | Ann Arbor | Michigan |
| Cleveland Clinic, Cole Eye Institute | 44195 | Cleveland | Ohio |
| Sheilds and Sheilds, PC | 19107 | Philadelphia | Pennsylvania |
| Tennessee Retina, PC | 37203 | Nashville | Tennessee |
| Retina Consultants of Texas | 77401 | Bellaire | Texas |
| University of Washington | 98104 | Seattle | Washington |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.